Literature DB >> 7811018

Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis.

L G Wayne1, H A Sramek.   

Abstract

Very abrupt exposure to anaerobic conditions has a lethal effect on actively growing cultures of Mycobacterium tuberculosis. However, incubation under conditions in which oxygen is depleted gradually causes M. tuberculosis to shift down from active replication to dormancy. The dormant bacilli are resistant to the bactericidal effects of anaerobiosis and also exhibit partial or complete resistance to the bactericidal effects of isoniazid and rifampin. On the other hand, metronidazole, a drug specific for anaerobes, kills dormant tubercle bacilli under anaerobic conditions, but it has no effect on actively growing aerobic cultures. The lethal effect of metronidazole under anaerobic conditions is enhanced by rifampin. The possible implications of these findings on the phenomenon of latency in tuberculosis are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7811018      PMCID: PMC284683          DOI: 10.1128/AAC.38.9.2054

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Enumeration of viable tubercle bacilli from the organs of nonimmunized and immunized mice.

Authors:  J L SEVER; G P YOUMANS
Journal:  Am Rev Tuberc       Date:  1957-10

2.  Ineffectiveness of isoniazid in modifying the phenomenon of microbial persistence.

Authors:  R McCUNE; S H LEE; K DEUSCHLE; W McDERMOTT
Journal:  Am Rev Tuberc       Date:  1957-12

3.  Mode of action of rifampin on mycobacteria. II. Biosynthetic studies on the inhibition of ribonucleic acid polymerase of Mycobacterium bovis BCG by rifampin and uptake of rifampin- 14 C by Mycobacterium phlei.

Authors:  K Konno; K Oizumi; S Oka
Journal:  Am Rev Respir Dis       Date:  1973-06

4.  Autolysis and secondary growth of Mycobacterium tuberculosis in submerged culture.

Authors:  L G Wayne; G A Diaz
Journal:  J Bacteriol       Date:  1967-04       Impact factor: 3.490

5.  A mouse model of the recrudescence of latent tuberculosis in the elderly.

Authors:  I M Orme
Journal:  Am Rev Respir Dis       Date:  1988-03

6.  Synchronized replication of Mycobacterium tuberculosis.

Authors:  L G Wayne
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

7.  Dynamics of submerged growth of Mycobacterium tuberculosis under aerobic and microaerophilic conditions.

Authors:  L G Wayne
Journal:  Am Rev Respir Dis       Date:  1976-10

8.  [Sterilizing activity of the main drugs on the mouse experimental tuberculosis (author's transl)].

Authors:  J Grosset; C Truffot; J Fermanian; H Lecoeur
Journal:  Pathol Biol (Paris)       Date:  1982-06

9.  Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis.

Authors:  J M Dickinson; D A Mitchison
Journal:  Am Rev Respir Dis       Date:  1981-04

10.  Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy.

Authors:  R M MCCUNE; R TOMPSETT
Journal:  J Exp Med       Date:  1956-11-01       Impact factor: 14.307

View more
  102 in total

1.  Proteins of Mycobacterium bovis BCG induced in the Wayne dormancy model.

Authors:  C Boon; R Li; R Qi; T Dick
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

Review 2.  Why metronidazole is active against both bacteria and parasites.

Authors:  J Samuelson
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

3.  The stringent response of Mycobacterium tuberculosis is required for long-term survival.

Authors:  T P Primm; S J Andersen; V Mizrahi; D Avarbock; H Rubin; C E Barry
Journal:  J Bacteriol       Date:  2000-09       Impact factor: 3.490

4.  In vitro activities of mitomycin C against growing and hypoxic dormant tubercle bacilli.

Authors:  H L Peh; A Toh; B Murugasu-Oei; T Dick
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

Review 5.  Tuberculosis: latency and reactivation.

Authors:  J L Flynn; J Chan
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

6.  Metronidazole therapy in mice infected with tuberculosis.

Authors:  J V Brooks; S K Furney; I M Orme
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

7.  Comment on: Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae.

Authors:  Tathagata Mukherjee; Helena Boshoff; Clifton E Barry
Journal:  J Antimicrob Chemother       Date:  2011-10-07       Impact factor: 5.790

Review 8.  New antituberculous drugs in development.

Authors:  Umesh G Lalloo; Anish Ambaram
Journal:  Curr HIV/AIDS Rep       Date:  2010-08       Impact factor: 5.071

9.  Examining the basis of isoniazid tolerance in nonreplicating Mycobacterium tuberculosis using transcriptional profiling.

Authors:  Griselda Tudó; Ken Laing; Denis A Mitchison; Philip D Butcher; Simon J Waddell
Journal:  Future Med Chem       Date:  2010-08       Impact factor: 3.808

10.  Severe recurrent Crohn's disease of ileocolonic anastomosis and antimicrobial (anti-mycobacterial) therapy.

Authors:  T J Borody; L B Heifets
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.